Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin for prevention of febrile episodes in non-Hodgkin lymphoma patients receiving R-CHOP
TCTR20230719005Phase 3Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin in non-Hodgkin lymphoma (NHL), sponsored by Ratchadaphiseksomphot Endowment Fund. Started Jan 2023; status: completed.
02
Drugs
levofloxacin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on TCTR20230719005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230719005.